Immunotoxins for targeted cancer therapy

This publication has 78 references indexed in Scilit:

• Expression of GM-CSF and a Functional GM-CSF Receptor in the Human Colon Carcinoma Cell Line SW403
  Biochemical and Biophysical Research Communications, 1995
• TGFα-PE40 inhibits non-small cell lung cancer growth
  Life Sciences, 1994
• Cytotoxic effect of a fusion protein from transforming growth factora andPseudomonas exotoxin on rat and human bladder carcinoma cells in vitro
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1994
• Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusion
  International Journal of Immunopharmacology, 1993
• Efficacy of an anti-CD5-ricin a chain immunoconjugate in an improved human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mouse model
  International Journal of Immunopharmacology, 1993
• Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer
  Cancer Immunology, Immunotherapy, 1992
• A proper amino terminus of diphtheria toxin is important for cytotoxicity
  Biochemical and Biophysical Research Communications, 1991
• Demonstration of high-affinity interleukin-2 receptors on B-chronic lymphocytic leukemia cells: Functional and structural characterization
  Annals of Hematology, 1990
• Epidermal growth factor-toxin A chain conjugates: EGF-Ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxic
  Cell, 1980
• Preparation of a hybrid of fragment Fab' of antibody and fragment a of diphtheria toxin and its cytotoxicity
  Biochemical and Biophysical Research Communications, 1979